Obesity may reduce the effectiveness of the anti-coronavirus vaccine

Cairo – Egypt today

A Turkish scientific study showed that the disease obesity It may impair the effectiveness of emerging coronavirus vaccines in those who have never had the virus, according to Archyde.com. Obese people had antibody levels three times lower than individuals of normal weight. Among those who received the Sinovac coronavirus vaccine, those who were obese and had no history of previous infection had antibody levels 27 times lower than people of normal weight. , according to data presented this week at the European Congress on Obesity in Maastricht, the Netherlands.

By comparison, in the 70 volunteers with pre-existing MERS infection, antibody levels were similar in obese and non-obese people. For the study, researchers compared the immune responses to vaccines in 124 obese volunteers, defined as their body mass index. 40 or higher, 166 individuals of normal weight, i.e. BMI less than 25. Overall, 130 participants received two doses of Pfizer and 160 participants received two doses of Sinovac inactivated virus vaccine. Whereas two doses of Pfizer vaccine may generate many antibodies. In obese people, more research is needed to determine whether these higher antibody levels provide greater protection once morest Corona Virus.

You may also be interested in:

“Obesity” makes ethnic minorities more vulnerable to infection with “Covid-19”

Fasting two days a week helps obese patients lose weight